SKYE Stock Price
Skye Bioscience, Inc.
SKYE stock price is $1.57 (+2.61% on the day), giving Skye Bioscience, Inc. a market cap of $6.77M. Below are the price chart, the MarketXLS Rank, the company profile and the latest news.
SKYE Stock Overview
- Price
- $1.57
- Previous close
- $1.53
- Open
- $1.53
- Market cap
- $6.77M
- P/E ratio
- -0.1
- 52-week range
- $1.50 - $13.60
- 1-year price target
- $60.80
- Sector
- Healthcare
- Industry
- Biotechnology
- Exchange
- NSC
- MarketXLS Rank
- 30
About Skye Bioscience, Inc.
Skye Bioscience, Inc., a biopharmaceutical company, focuses on unlocking new therapeutic pathways for metabolic health through the development of molecules that modulate G-protein coupled receptors. The company's lead product candidate is nimacimab, a negative allosteric modulating antibody that peripherally inhibits CB1, which is in Phase 2 clinical trial. This study is also assessing the combination of nimacimab and a GLP-1R agonist (Wegovy). The company was formerly known as Emerald Bioscience, Inc. and changed its name to Skye Bioscience, Inc. in January 2021. The company is headquartered in San Diego, California.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | SKYE | $1.57 | +2.6% | 34.44K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |